Kim A Reiss

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Bioinformatics Analysis

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

This page only lists publications with an associated author ORCID identifier.

Publications

Minh T Than, Mark H O'Hara, Ben Z Stanger, Kim A Reiss
KRAS-driven Tumorigenesis and KRAS-driven Therapy in Pancreatic Adenocarcinoma. Molecular cancer therapeutics (2024)
Timothy J Brown, Kim A Reiss, Mark H O'Hara
Advancements in Systemic Therapy for Pancreatic Cancer. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 43 (2023)
Timothy J Brown, Arielle Yablonovitch, Jacob E Till, Jennifer Yen, Lesli A Kiedrowski, Ryan Hood, Mark H O'Hara, Ursina Teitelbaum, Thomas Benjamin Karasic, Charles Schneider, Erica L Carpenter, Katherine L Nathanson, Susan M Domchek, Kim A Reiss
The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kim A Reiss, Rosemarie Mick, Mark H O'Hara, Ursina Teitelbaum, Thomas Benjamin Karasic, Charles Schneider, Stacy Cowden, Traci Southwell, Janae Romeo, Natallia Izgur, Zain M Hannan, Rashmi Tondon, Katherine L Nathanson, Robert H Vonderheide, Max M Wattenberg, Gregory Beatty, Susan M Domchek
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)